Allarity Therapeutics (ALLR) Misses Q3 EPS by 19c
Tweet
Share
E-mailGet Alerts ALLR Hot Sheet
Join SI Premium – FREE
Allarity Therapeutics (NASDAQ: ALLR) reported Q3 EPS of ($0.19).
For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Boeing wins $2 billion satellite contract from DoW
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
